HLHeloisa Silva Leal

Heloisa Silva Leal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Heloisa Silva Leal has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Avaliação do perfil clínico-epidemiológico dos óbitos por COVID-19 em homens e mulheres adultos no estado do Maranhão

    by Gustavo Soares Gomes Barros Fonseca, Rodrigo Sevilla Noleto, Luciana Martinuzzi Breitenbach, Heloisa Silva Leal, Maria Eduarda de Carvalho Penha Carneiro, Lindomar Faria de Freitas Júnior, Felipe Teixeira Costa, Ana Emanuelle Ribeiro Nunes Carvalho, Fabricia Carvalho Dourado Pereira, Victor Matheus Santos da Silva, et al.

    The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has spread worldwide and caused Coronavirus Disease 2019 (COVID-19) in approximately 46 million people by November 2020, configuring a pandemic after an alert from the World Health Organization. The most prevalent comorbidities of patients infected with SARS-CoV-2 are systemic arterial hypertension and diabetes mellitus. Such patients who frequently undergo treatment with angiotensin-converting enzyme 2 inhibitors or angiotensin II type I receptor blockers have a considerable increase in the expression of angiotensin-converting enzyme 2 (ACE2) receptors, facilitating the entry of the coronavirus. These same patients end up developing a worse prognosis of the pathology, which can be lethal. Other studies have shown that adult women and men respond differently to SARS-CoV-2 infection. The expression of ACE2 is influenced by sex hormones, thus, it would be one of the reasons for the higher male prevalence. In Maranhão, cases of infection were initially investigated at the end of February, with two suspects. Regarding mortality, males had a higher rate (62%), which shows the relevance of gender in the prognosis. The present research intends to analyze, through a data collection, the clinical-epidemiological profile of deaths by COVID-19 in adult men and women in the state of Maranhão, establishing a comparison between the symptoms of COVID-19, considering not only the epidemiological profile, as well as the sociodemographic profile and associated morbidities, in addition to discussing the incidence of forms of severity of the disease in both sexes.

  • Open Access

    Cirrose hepática e suas principais etiologias: Revisão da literatura

    by Gustavo Soares Gomes Barros Fonseca, Jusciellyson da Silva Nava, Rodrigo Sevilla Noleto, Victor de Castro Araujo, Luciana Martinuzzi Breitenbach, Bruno Martins Milhomem, Yasmin de Matos Capistranio, Laís Jaciara Costa Revil Ferreira, Júlio Cézar Martins Frazao, Lindomar Faria de Freitas Júnior, et al.

    Liver cirrhosis is a pathological healing process, irreversible in its advanced stages with complications that can be lethal. Chronic injury causes inflammation and liver fibrosis, with consequent formation of septa and fibrous regenerating nodules, which can lead to future complications such as portal hypertension. Among its causes are viral hepatitis, alcoholic hepatitis, non-alcoholic fatty liver disease, autoimmune, cholestatic and storage diseases. Non-invasive fibrosis tests are useful to define the degree of disease progression, in order to intervene and define the best management for each patient. Antifibrotic therapies currently aim to inactivate the differentiation of hepatic stellate cells, responsible for fibrotic progression. However, they are still in the testing phase, but they seem to be promising. This is a systematic literature review, of a quantitative nature, which used the platforms PubMed (Medline), Scientific Electronic Library On-line (SciELO) and Cochrane Library as databases for the selection of articles, in English. The choice of articles was carried out by reading the title, abstract and, finally, reading the article in its entirety, with a careful analysis based on the inclusion and exclusion criteria. It is concluded, therefore, that the main etiologies of liver cirrhosis are viral hepatitis, alcoholic hepatitis and non-alcoholic fatty liver disease. It was observed that the different etiologies cause different forms of fibrotic evolution, which depend on the origin of the cell types and mechanisms involved, fundamental to assess at which stage the therapy would have the maximum performance.